PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex
Fierce Pharma
DECEMBER 1, 2022
PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex. Thu, 12/01/2022 - 11:05.
Fierce Pharma
DECEMBER 1, 2022
PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex. Thu, 12/01/2022 - 11:05.
Pharmacy Times
SEPTEMBER 8, 2022
Patients should discuss efficacy and potential drug interactions with clinicians before use, study authors indicate.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JANUARY 25, 2022
The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder.
BuzzRx
SEPTEMBER 30, 2022
Food and Drug Administration approved Epidiolex , the first plant-based CBD (cannabidiol) formulation for the treatment of two rare forms of childhood-onset epilepsy: Lennox-Gastaut syndrome (LGS) and Dravet syndrome. This CBD oral solution can be used in adults and children as young as 1 year old. This has led the U.S.
The Checkup by Singlecare
APRIL 27, 2023
The use of cannabidiol (CBD), whether in oils, gummies, or creams, is rapidly growing in the United States. In 2022 alone, the consumer market size for CBD reached around $16 billion and is expected to nearly quadruple by 2032. Taking CBD and blood thinners, in particular, could lead to serious drug interactions and adverse effects.
DiversifyRx
AUGUST 4, 2022
Have you been on the sidelines regarding selling CBD in your pharmacy? No matter where you are in your CBD journey, let’s get your pharmacy ready to help patients and boost your pharmacy profit. You might be thinking that all CBD products seem the same. When talking to potential CBD companies, ask what makes them special.
Hospital Pharmacy Europe
NOVEMBER 6, 2022
Cannabidiol (CBD) given as a full-spectrum (i.e., For example, CBD has been found to be effective in patients with generalised social anxiety disorder although to date, only one randomised trial has been undertaken. While previous research has examined the anxiolytic action of CBD, this is usually with a highly purified version.
Let's personalize your content